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The goal of the current paper is to explore the role of liver biopsy as a tool in detection of hepatic oxidative stress, with brief notes
on diﬀerent types of free radicals, antioxidants, hepatic and blood oxidative stress, and lipid peroxidation. Hepatic oxidative stress
wasinvestigated formanyyearsinhumanandanimals,butmostofthestudiesperformedinanimalswereconcernedwithstudying
oxidative status in the liver tissues after slaughtering or euthanasia. However, in human medicine, a large number of studies were
implemented to investigate the status of antioxidants in liver biopsy specimens. Similar studies are required in animals, as the
changes in hepatic antioxidants and formation of lipid peroxide give a good idea about the condition of the liver. On the other
hand, hepatic disease may present without signiﬁcant eﬀect on blood oxidative status, and, consequently, the best way to detect
the status of hepatic oxidants and antioxidants is through measuring in liver biopsy. Measuring antioxidants status directly in the
liver tissues gives an accurate estimation about the condition of the liver, permits the diagnosis of hepatic dysfunction, and helps
to determine the degree of deterioration in the hepatic cells.
1.Introduction
Free radicals are highly reactive substances produced contin-
uously during metabolic processes. They participate mainly
in physiological events such as the immune response,
metabolism of unsaturated fatty acids, and inﬂammatory
reaction. The balance between free radicals and antioxidants
is disrupted in many diseases. This disruption may be
attributed to a number of factors such as the inability of
the cells to produce suﬃcient amounts of antioxidants, the
nutritional deﬁciencyof minerals or vitamins, and the excess
production of reactive oxygen species [1]. Free radical excess
results in impairment of DNA, enzymes, and membranes
and induces changes in the activity of the immune system
andinthestructureofbasicbiopolymerswhich, inturn,may
be related to mutagenesis and aging processes [2].
The involvement of oxidative stress in the pathogenesis
of hepatic dysfunction in human [2–15] and animals [1, 16–
25] has been investigated for many years. Some of the liver
diseases were associated with an increase [21, 24, 26]o r
decrease [17, 22, 27–29] in antioxidant’s contents. Usually
hepatic antioxidants increase at the beginning of hepatic
disease and decrease in severe hepatic injury. The advantages
of measuring hepatic oxidative status in liver biopsy are
that it helps in diagnosis of hepatic dysfunction, reﬂects
the degree of deterioration in the liver tissues, and helps to
determine the severity of hepatic injury, and, also, it aids
in recommending antioxidant’s therapy in patients that had
a hepatic disease with derangement in hepatic antioxidant
constituents. The main purpose of the current paper is to
explore the value of liver biopsy as a tool for detection of
hepatic oxidative stress. A focus was done on diﬀerent types
of free radicals, antioxidants, lipid peroxidation, and hepatic
and blood oxidative status in hepatic dysfunction.
2.FreeRadicals
2.1. Types of Free Radicals. Free radicals can be deﬁned as
molecules containing a single unpaired electron in atomic
or molecular orbits. These molecules have an important
role in the pathogenesis of tissue damage in various dis-
orders [30], such as hepatic dysfunction, mastitis, kidney
damage, inﬂammation, immune injury, and carcinogenesis2 Veterinary Medicine International
[1]. The most important free radicals include superoxide
anion (O2
•−), hydroxyl radical (•OH), and hypochlorous
acid (HOCL) [31]. HOCL is produced by the reaction of
hydrogen peroxide (H2O2) with chloride ions and plays an
important role in the leukocyte respiratory burst, which
is involved in the host defense system [32]. Nitric oxide
(NO•) acts as a free radical and as a biological mediator in
biochemical reactions. Physiologically it is synthesized from
L-arginine by NO synthase employing cofactor NADPH. In
the host, NO• arises in some pathological situations, such
as sepsis, stroke, myocardial depression, and inﬂammatory
responses [33].
Superoxide anion induces important reducing reactions
in biological materials via Fenton-like reactions, which
are catalyzed by redox cycling metal ions, including iron,
copper, chromium, and vanadium [34]. These metal ions
have the ability to accept and donate single electrons,
making them important catalysts of free radical reactions;
the most widely distributed and most commonly studied
transition metal ions are the cations iron and copper [31].
Superoxide anion reduces Fe3+ in metalloproteins such
as ferritin. The reduction of protein bound iron is an
important reaction in biological material, because if there is
suﬃcient H2O2 available, a reaction between the resultant
Fe2+ and H2O2 occurs and gives rise to the highly reactive
•OH [32], and H2O2 traverses biological membranes and
intracellularlytargetsphospholipids,carbohydrates,metallo-
proteins, and DNA and causes damage via Fenton’s reaction
[35].
2.2. Sources of Free Radicals. Free radicals may be released in
the liver as a subsequence to hepatic detoxiﬁcation of drugs,
chemicals, and toxic materials [36, 37]. The formation of
oxygen free radicals may be physiological as in phagocytosis
(superoxide and H2O2 are used by phagocytic cells to kill
bacteria), a side eﬀect of metabolic pathways, or may occur
in pathological conditions due to toxic agents as in the case
of ischemia, inﬂammation, and disease, or due to decreased
antioxidant defenses [38].
Mitochondria are considered a major source for the pro-
ductionofO2
•− and H2O2; about2-3% ofconsumedoxygen
isconstantlyconvertedintoreactiveoxygen/reactivenitrogen
species(ROS/RNS)inthemitochondria;hepatocytescontain
many mitochondria and therefore generate excess ROS/RNS
[31].
In many liver diseases, including the wide range of
neonatal hepatitis, the tissue inﬂammatory inﬁltrates are
likely to be responsible for the formation of O2
•−,H 2O2,
•OH, HOCL, and the highly cytotoxic monochloramine
[39, 40]. In turn, the superoxide anion attracts further neu-
trophils to the inﬂammatory site by a chemotactic activity,
causing an increase in tissue injury [41]. In addition, acti-
vated macrophages, Kupﬀer cells, and vascular endothelium
can generate nitric oxide, which may react with superoxide
generating peroxynitrite. The latter is responsible for the
inhibition of mitochondrial respiration and DNA synthesis
[42].
Liverdamageduetoiron (hemochromatosis) and copper
overload is believed, at least partially, to derive from the
catalytic activity of these metals in the Fenton reaction
leading to the generation of ROS and increased lipid perox-
idation with consequent abnormal mitochondrial function
[43–45].
3.Antioxidantsand Free Radicals
The cells contain a variety of antioxidant mechanisms
that play a central role in the protection against reactive
oxygen species [46, 47]. The antioxidant system consists
of antioxidant enzymes (superoxide dismutase (SOD),
catalase and glutathione peroxidase (GSH-Px)), glutathi-
one, ancillary enzymes (glutathione reductase (GR), glu-
tathione S-transferase, and glucose 6-phosphate dehydroge-
nase (G6PD)), metal-binding proteins (transferrin, cerulo-
plasmin, and albumin), vitamins (alpha-tocopherol, ascor-
bate, and beta-carotene), ﬂavonoids, and urate [48].
Pathological free radical reactions do not necessarily
cause cell and tissue damage, as antioxidants of cells and
tissues are able to prevent free radical injury [36]. On the
intracellular level, ROS formation and metabolism can be
summarized as shown in Figure 1.
4.HepaticOxidativeStress
and LipidPeroxidation
Oxidative stress results when reactive forms of oxygen are
produced faster than they can be safely neutralized by
antioxidant mechanisms [49]a n d / o rf r o mad e c r e a s ei n
antioxidant defense, which may lead to damage of biological
macromolecules and disruption of normal metabolism and
physiology [50]. This condition can contribute and/or lead
to the onset of health disorders [38] and play a damaging
role in a number of liver disorders, for example, in anoxic
and reoxygenation injury during transplantation, activated
phagocytes and xanthine oxidase formed during ischemia,
catalyzing the formation of superoxide during reperfusion
[39, 51–53].
Lipid peroxidation is implicated in the pathogenesis of
several hepatic disorders in human [2, 26] and animals [18,
22]. Hepatic failure in cattle was associated with decreased
antioxidant mechanisms inside the cells, which led to the
increase in the reactive oxygen species, especially H2O2.T h e
decrease in hepatic GSH-Px activity in severe fatty degen-
eration, for example, results in the increase of H2O2 [22],
which can initiate free radical formation through Fenton’s
reaction. In addition, the decrease in hepatic vitamin E
level, which is an important chain-breaking antioxidant,
results in lipid peroxidation and failure to regenerate the
ascorbic acid [17, 18]. Increased hepatic oxidative stress was
also reported in cows suﬀering from glycogen degeneration
[22], sawdust liver, and liver abscesses [19, 21]. The authors
contended that the antioxidant defense was high in the case
of sawdust liver, glycogen degeneration, and liver abscess,
which indicated that the body can combat the increased free
radical stress.Veterinary Medicine International 3
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Figure1:Shownarediﬀerent types ofreactive oxygenspecies (ROS).Abbreviations:GSH-Px: Glutathioneperoxidase; HOCl:Hypochlorous
acid; H2O2: Hydrogen peroxide; MPO: Myeloperoxidase; NO•:N i t r i co x i d e ;N O S :N Os y n t h a s e ;O 2
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GR: Glutathione reductase; G6PD: Glucose-6-phosphate dehydrogenase.
Liver abscesses in fattening steers occur mainly due to
intensive feeding of highly concentrated rations. Consump-
tion of a carbohydrate-rich diet stimulates G6PD expression
in endothelial and parenchymal cells [16, 19]. Since G6PD
supports reactive oxygen metabolism, the response may rep-
resent an antioxidant pathway in the hepatic cell populations
that targets sinusoid born reactive oxygen species during
infections [19, 21].
Underfeeding in cattle was reported to induce changes
in the antioxidant systems in liver manifested by lowering
hepaticG6PDandSODactivities. Thisresultsin depletionof
antioxidantdefensemechanisms andrendersthehepatocytes
more susceptible to the lethal eﬀects of endogenous or
exogenous peroxides, and it indicates that the generation
of lipid peroxides in cattle in poor nutritional condition
exceeds the antioxidant capacity of the liver cells, generating
a situation of oxidative stress and peroxidation [20].
The leading mechanism of free radical toxicity is the
peroxidation of membrane phospholipids, which is initiated
by the formation of lipid peroxide or hydroperoxides, and
peroxyradicalsareformedinthepresenceofoxygentostarta
chain reaction (propagation) [2, 54, 55]. Various pathogenic
eﬀects occur as the result of degradation of membrane lipids
[31]. Chieﬂy, the hydroxyl radical and to a lesser extent the
superoxide anion leads to peroxidation of membrane lipids
thereby causing production of malondialdehyde (MDA)
and 4-hydroxyalkenals (4HNE). These substances directly
induce hepatocytes damage with generation of proinﬂam-
matorycytokines,activationofspindlecells,and ﬁbrogenesis
[56, 57] and may bind to various molecules, impairing their
functions [5] and therefore lead to membrane damage,
protein damage, enzyme dysfunction, and DNA or RNA
damage [58]. It is well known that persistent oxidant
stress causes mutative eﬀects on cell DNA and increases
ﬁbroblastic activity, leading to cirrhosis and carcinoma.
Many studies have shown that oxidative stress takes part in
thepathogenesisofcholestasisbywayofcytokines[8, 11–13]
and lipid peroxidation [6].
The role of lipid peroxidation in liver ﬁbrosis was
assessed. Lipid peroxidation products in the form of MDA
adduct were detected in areas of active ﬁbrogenesis. It has
been shown that lipid peroxidation products can stimulate
ﬁbrogenesis by inducing collagen gene expression, and
detection and prevention of lipid peroxidation could be of
major interest in preventing ﬁbrosis and cirrhosis in this
disease [9].
Increased lipid peroxidation may be caused by inﬂam-
mation related to viral infection and decreased antioxidant
levels.Thelipidperoxidesformedmaybechemotacticforthe
neutrophils causing increased inﬂammation, which further
drives oxidant-mediated injury in the liver [59]. Previous
studies have demonstrated an increase in MDA levels and
decrease of the antioxidant capacity in acute and chronic
hepatitis [3, 4, 55]. Mitochondrial lipid peroxidation takes
place at varying levelsin liver disorders independent of etiol-
ogy [44, 60]. Increased lipid,protein, and nucleicacid perox-
idationinthebloodandliverbiopsyspecimensfrompatients
with chronic hepatitis has been demonstrated [7, 15, 26].4 Veterinary Medicine International
Table 1: Methods for preparation of liver biopsy implemented in diﬀerent studies.
Tissue preparation Buﬀer used Homogenization
Oxidative
stress
marker
Reference
Tris-HCL (50 mM) pH 7.5
The liver biopsy was homogenized in 20 volumes of
cold buﬀer, and then the supernatant was harvested
after centrifugation at 5000g for 30min at 4◦C.
SOD, CAT
and GSH [24, 25]
Chilled potassium chloride
(1.17%)
Liver biopsy was homogenized in chilled buﬀer. The
homogenates were centrifuged at 800g for 5min at
4◦C to separate the nuclear debris. The obtained
supernatant was recentrifuged at 10,500g for 20min
at 4◦C to get the postmitochondrial supernatant.
SOD, CAT
and MDA [68]
Liver biopsy
samples were
washed twice in cold
0.9% salt solution
Ice-cold PBS buﬀer (20mM),
p H7 . 3w i t h1 0m lo f5m M
butylated hydroxyl toluene
The tissue was homogenized in 290ml ice-cold
buﬀer. Following this, the suspension was centrifuged
and supernatant was fractioned for analysis.
LPO and
AOP [69]
Tris-HCl (50 mM), pH 7.5,
5mMEDT A,1nM
dithiothreitol
The tissue was homogenized in 5ml/g cold buﬀer.
The homogenate was centrifuged at 10,000g for 15
minutes at 4◦C. The supernatant was removed for
assay.
GSH-Px [70]
Potassiumphosphate
(0.05M) and 0.1mM EDTA,
pH 7.8
The tissue was homogenized in 200μLb u ﬀer and
centrifuged at 15,000g for 30 minutes at 4◦C. The
supernatant was used for analysis.
SOD [70]
5.OxidativeStressandHepaticDysfunction:
RoleofLiverBiopsy
5.1.BloodandHepaticOxidative Stress. Antioxidantstatusof
blood does not reﬂect hepatic oxidative stress only, but their
levels change in response to diseases in other organs. Study-
ingtheeﬀectofhepaticdysfunctiononbloodoxidativestatus
in cows revealed that hepatic glycogen degeneration, fatty
degeneration, or liver abscesses had no eﬀect on erythrocytic
oxidative status, as indicated by the insigniﬁcant changes in
erythrocytes GSH-Px and G6PD activities [21, 22]. Many
studies had been performed on humans to determine the
eﬀectofhepaticdysfunction onerythrocyticoxidativestatus;
some of these studies had reported no signiﬁcant changes
in erythrocytes GSH-Px activity in patients suﬀered from
liver cirrhosis and alcoholic liver disease [61–63]. Other
s t u d i e sh a dd e m o n s t r a t e dt h a tar e dc e l lG S H - P xa c t i v i t y
signiﬁcantly decreased in patients with chronic liver disease
[64–66]. In addition, lower activities of erythrocytes GSH-
Px and SOD activities have been reported in patients with
acutehepatitisB[67].Thecauseofsuchcontradictoryresults
may be related to the degree of hepatic dysfunction or
the presence or absence of selenium deﬁciency. Signiﬁcant
decreases in plasma selenium level and erythrocytes GSH-Px
had been reported in patients with chronic liver disease [64].
Increased oxidative stress had been reported in the liver
of cattle with naturally occurring fatty liver [18, 22], with
liver abscessation [21], and in animals on restricted feed
intake [20], without signiﬁcant changes in blood oxidative
status; this means that hepatic disease may present without
eﬀect on blood oxidative status and also that detection
of hepatic oxidative stress is best done through measuring
oxidative stress markers in the hepatic tissues by means of
liver biopsy.
5.2. Preparation of Liver Biopsy for Antioxidants Measure-
ments. The principles for preparation of liver biopsy are
that liver biopsy must be prepared directly after collection,
otherwise storedat −80◦C,liverbiopsymustbewashed twice
in a cold saline or cold buﬀer before homogenization, blot
dry, and then homogenized in a cold buﬀer at certain pH.
After centrifugation, the supernatant is harvested and used
to measure hepatic antioxidant enzyme activities, which can
be performed using commercial test kits (Table 1).
5.3. Liver Biopsy and Oxidative Stress. Oxygen free radicals
might play a role in the pathogenesis of tissue damage in
many pathological conditions and have been implicated in
a variety of liver diseases. It, therefore, may participate in the
pathogenesis of toxic liver diseases and other hepatic alter-
ations [10]. Oxidative stress is a major pathogenetic event
occurring in several liver disorders ranging from metabolic
to proliferated ones and is a main cause of liver damage in
ischemia/reperfusion during liver transplantation [14].
The involvement of oxidative stress in the pathogenesis
of liver injury has been investigated for many years [2–4].
Some of these studies were conducted using liver biopsy
in human [70, 71] and animals [24, 25]. But most of the
studies in animals measured hepatic oxidative stress after
slaughtering or euthanasia. Examples include measuring
hepatic G6PD activity in chemically induced hepatocellu-
lar carcinoma in rat liver [72]a n di nl i v e ro fr a tw i t h
macronodular cirrhosis inducedby long-termthioacetamide
administration [73]. In cattle, hepatic GSH-Px activity [22]Veterinary Medicine International 5
and vitamin E [17, 18] were measured in cows suﬀering
from severe fatty degeneration. In addition, hepatic GSH-Px
and G6PD activities were determined in cows suﬀering from
glycogendegeneration [22], sawdust liver, and liver abscesses
[16, 19, 21]. Furthermore, hepatic G6PD and SOD activities
were measured in cows with restricted feed intake [20].
Recently, liver biopsy was applied as a tool for detecting
hepatic oxidative stress in cattle from the viewpoint of
the status of hepatic antioxidant enzymes after injection
of a potent hepatotoxic (DL-ethionine), data published in
[24, 25]; the supernatant of liver homogenate was used to
measure hepatic SOD, catalase [25], total glutathione level
and glutathione reductase activity [24].
Manystudieswereperformedtoestablishtheimportance
of liver biopsy from the viewpoint of oxidative stress in a
variety of liver disorders in human. Examples in human
include the following oxidative stress-related parameters
were investigated in liver biopsy from NAFLD patients and
used to assay activities of CAT and GSH-Px [28]. Oxidative
stress status in children with glycogen storage disease [74]
and with cholestatic chronic liver disease [70] was investi-
gated by measuring GSH-Px, SOD, and CAT activities in
liver biopsy samples. Activities of SOD, CAT, and GSH-Px
were measured in liver biopsy specimens from patients with
various liver diseases, including chronic persistent hepatitis,
chronic active hepatitis, nonalcoholic cirrhosis, alcoholic
cirrhosis, and acute hepatitis [71].
Increased hepatic oxidative stress had also been detected
in liver biopsy from patients with cirrhosis and hepatocel-
lular carcinoma, shown by the decrease of GSH-Px activity,
hepatic and blood glutathione (GSH) levels, along with
an increase in the oxidized glutathione/glutathione ratio in
cirrhotic [26, 27] and liver cancer tissues [29], which reﬂects
a decrease in both the synthesize capacity of liver and the
antioxidant defense.
It is clearfrom the abovereview ofthe literaturethat liver
biopsy can be used for measuring oxidative status of the liver
tissues and that signiﬁcant changes were detectedin diﬀerent
hepatic dysfunctions. Antioxidant activities in liver biopsy
can be used to diagnose liver disease and as a prognostic
f a c t o rf o rt h el i v e rd i s e a s eu n d e ri n v e s t i g a t i o n .
6.Conclusion
Most of the studies done in animals were concerned with
studying the hepatic oxidative stress after slaughtering or
euthanasia. Studying the hepatic oxidative status in liver
biopsy is lacking in animals. In human medicine, a large
number of studies were implemented to achieve this goal.
Hepatic disease may present without signiﬁcant eﬀect on
blood oxidative status. Consequently, the best way is to
measure hepatic oxidants and antioxidants in liver biopsy,
which reﬂects the actual status of the liver.
Abbreviations
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AOP: Antioxidant potential
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•OH: Hydroxyl radical
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